Trial · NCT02952820
Participant flow24
How many started, completed or left each group, period by period.
1 to 20 of 24
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Placebo-Controlled Treatment (6 Months) | STARTED | Placebo | 325 | |
| Placebo-Controlled Treatment (6 Months) | STARTED | Lemborexant 5 mg | 323 | |
| Placebo-Controlled Treatment (6 Months) | STARTED | Lemborexant 10 mg | 323 | |
| Placebo-Controlled Treatment (6 Months) | Treated | Placebo | 321 | |
| Placebo-Controlled Treatment (6 Months) | Treated | Lemborexant 5 mg | 319 | |
| Placebo-Controlled Treatment (6 Months) | Treated | Lemborexant 10 mg | 319 | |
| Placebo-Controlled Treatment (6 Months) | Safety Analysis Set | Placebo | 319 | |
| Placebo-Controlled Treatment (6 Months) | Safety Analysis Set | Lemborexant 5 mg | 314 | |
| Placebo-Controlled Treatment (6 Months) | Safety Analysis Set | Lemborexant 10 mg | 314 | |
| Placebo-Controlled Treatment (6 Months) | COMPLETED | Placebo | 261 | |
| Placebo-Controlled Treatment (6 Months) | COMPLETED | Lemborexant 5 mg | 254 | |
| Placebo-Controlled Treatment (6 Months) | COMPLETED | Lemborexant 10 mg | 235 | |
| Placebo-Controlled Treatment (6 Months) | NOT COMPLETED | Placebo | 64 | |
| Placebo-Controlled Treatment (6 Months) | NOT COMPLETED | Lemborexant 5 mg | 69 | |
| Placebo-Controlled Treatment (6 Months) | NOT COMPLETED | Lemborexant 10 mg | 88 | |
| Active Treatment Period (6 Months) | STARTED | Placebo | 0 | |
| Active Treatment Period (6 Months) | STARTED | Lemborexant 5 mg | 384 | |
| Active Treatment Period (6 Months) | STARTED | Lemborexant 10 mg | 352 | |
| Active Treatment Period (6 Months) | COMPLETED | Placebo | 0 | |
| Active Treatment Period (6 Months) | COMPLETED | Lemborexant 5 mg | 346 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02952820/flow